<DOC>
	<DOCNO>NCT00499876</DOCNO>
	<brief_summary>The purpose study find whether malaria affect HIV/AIDS disease progress infected patient , determine effect reduce malaria infection HIV disease progression Kumasi</brief_summary>
	<brief_title>The Effect Malaria Disease Progression HIV/AIDS</brief_title>
	<detailed_description>Malaria HIV among prevalent infectious disease sub-Saharan Africa major cause morbidity mortality sub region . Because wide-spread geographical overlap HIV malaria , probability co-infections potential interaction two disease high . Even modest interaction may substantial impact population . It clear interaction two infection . HIV associate immunosuppression erodes malaria acquire immunity HIV patient . The risk parasitaemia , high parasite density malarial fever increase decrease CD4 T cell count increase viral load HIV patient . Plasmodium falciparum show stimulate HIV replication production cytokine ( include interleukin 6 tumor necrose factor α ( TNF-α ) ) activate lymphocyte . Malaria treatment HIV patient malaria result significant reduction median HIV viral load concentration . Although clear malaria cause transient rise HIV-1 viral load , could repeat episode malaria area intense transmission lead cumulative effect viral load accelerate decline CD4 count thereby accelerate HIV disease progression ? If , could decline CD4 count individual yet start anti-retroviral drug slow intermittent malaria treatment ? A controlled interventional study mefloquine malaria prophylaxis 6 month use HIV/AIDS patient already ARTs KATH , malaria parasitaemia density , HIV viral load CD4 cell count monitor arm . Comparison : Malaria parasitaemia density , HIV viral load CD4 cell count compare intervention group control group determine effect malaria malaria prophylaxis HIV disease progression</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Disease Progression</mesh_term>
	<mesh_term>Mefloquine</mesh_term>
	<criteria>Adult HIV patient attend Komfo Anokye Teaching Hospital ( KATH ) HIV clinic yet fulfil criterion ARTs . This include CD 4 cell count ≥ 300x106/l World Health Organisation HIV stage IIII All child HIV infection attend HIV clinic KATH Adult HIV patient ARTs attend HIV clinic KATH Adult HIV patient WHO stage IV V AIDS</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Human immune deficiency virus</keyword>
	<keyword>Acquired immune deficiency syndrome</keyword>
	<keyword>malaria</keyword>
	<keyword>mefloquine</keyword>
	<keyword>prophylaxis</keyword>
	<keyword>HIV/AIDS</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>